|
Depression 5-HTP L-dopa
Neurotransmitter Uptake
In order for the synthesis of
monoamine neurotransmitters to
occur, the amino acid precursors
must undergo uptake into the
cells performing synthesis.
This process occurs in numerous
places throughout the body
including the central nervous
system, kidneys, liver,
gastrointestinal tract,
mesentery, lungs and peripheral
nerves. The “cation uptake
ports” found in the proximal
convoluted renal tubule cells
are a prototype for amino acid
uptake.
Neurotransmitters synthesized
by the kidneys are the source of
urinary serotonin and
catecholamines. Serotonin and the
catecholamines are synthesized
by the kidneys, then excreted
into the urine or secreted into
the system via the renal veins.20
Uptake is affected by
administration of a single amino
acid precursor or improperly
balanced amino acid precursors
as may overwhelm and compete
with uptake of the other amino
acids. Administration of only
L-dopa inhibits uptake of 5-HTP.
Administration of only 5-HTP has
the same effect on L-dopa
uptake.
Depression 5-HTP L-dopa
Neurotransmitter Uptake
|
|
|
|
Its no secret, NeuroResearch Clinics uses the nutrients 5-HTP, tyrosine, levodopa,
and cysteine to treat medical
patients in order to get these
results. Proper
use of these simple ingredients in
medical treatment is not simple.
From time to time a patient will
say, "Why do I want to take that, I
can go to a health food store and
buy it?" People off the street
buying in a health food store is
like going to an art store and
buying a bunch of oil paints then
going home and expecting to paint
like a mater artist even though
there was no previous painting
experience. These nutrients have
tremendous potential due to their
chemical properties. This potential
is only fully realized in the hands
of the trained professional using
neurotransmitter testing. Treatment
is not just giving a nutrient pill, it is the whole medical management approach doctors are trained in to insure that that treatment is on track in order to get symptoms under control.
The Peer Reviewed Research
of NeuroResearch Clinics
The neurotransmitter treatment research findings of NeuroResearch Clinics
have not been ignored. The University of
Minnesota Medical School is writing a series of
papers on the neurotransmitter testing research of NeuroResearch Clinics. The first of a series of papers by University of Minnesota Medical School based on the neurotransmitter testing research of NeuroResearch was published in "NeuroPsychiatric Disease and Treatment" May 1, 2009. Ingrid
Kohlstadt, MD of Johns Hopkins in her new
medical text book released February 7, 2009
included a chapter on depression written by
Marty L. Hinz, MD President Clinical
Research NeuroResearch Clinics outlining in
depth the proper use of amino acids and
neurotransmitter testing in treatment of
depression.
|
